Tg Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Tg Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tg Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tg Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $32M | 873k | 36.13 |
| 2025-06-30 | $33M | 907k | 35.99 |
| 2025-03-31 | $35M | 893k | 39.43 |
| 2024-12-31 | $28M | 924k | 30.10 |
| 2024-09-30 | $20M | 836k | 23.39 |
| 2024-06-30 | $9.0M | 504k | 17.79 |
| 2024-03-31 | $6.8M | 444k | 15.21 |
| 2023-12-31 | $8.1M | 474k | 17.08 |
| 2023-09-30 | $4.8M | 580k | 8.36 |
| 2023-06-30 | $15M | 590k | 24.84 |
| 2023-03-31 | $7.1M | 469k | 15.04 |
| 2022-12-31 | $5.9M | 497k | 11.83 |
| 2022-09-30 | $0 | 451k | 0.00 |
| 2022-06-30 | $1.7M | 399k | 4.26 |
| 2022-03-31 | $5.1M | 532k | 9.51 |
| 2021-12-31 | $0 | 532k | 0.00 |
| 2021-09-30 | $0 | 565k | 0.00 |
| 2021-06-30 | $21M | 532k | 38.79 |
| 2021-03-31 | $25M | 510k | 48.20 |
| 2020-12-31 | $28M | 528k | 52.02 |
| 2020-09-30 | $13M | 466k | 26.76 |
| 2020-06-30 | $0 | 436k | 0.00 |
| 2020-03-31 | $3.6M | 363k | 9.84 |
| 2019-12-31 | $3.6M | 325k | 11.10 |
| 2019-09-30 | $1.7M | 310k | 5.62 |
| 2019-06-30 | $2.7M | 311k | 8.65 |
| 2019-03-31 | $2.3M | 281k | 8.04 |
| 2018-12-31 | $1.1M | 278k | 4.10 |
| 2018-09-30 | $1.6M | 287k | 5.60 |
| 2018-06-30 | $3.6M | 276k | 13.15 |
| 2018-03-31 | $3.5M | 247k | 14.20 |
| 2017-12-31 | $2.0M | 246k | 8.20 |
| 2017-06-30 | $3.0M | 297k | 10.05 |
| 2017-03-31 | $3.2M | 272k | 11.66 |
| 2016-12-31 | $901k | 193k | 4.66 |
| 2016-09-30 | $1.4M | 176k | 7.74 |
| 2016-06-30 | $1.1M | 177k | 6.06 |